March 25, 2020 / 5:49 PM / 16 days ago

Mylan waives exclusive U.S. distribution rights for potential COVID-19 therapy

March 25 (Reuters) - U.S. drugmaker Mylan NV said on Wednesday it had waived its exclusive rights to U.S. distribution of its generic version of HIV treatment Kaletra, which is currently being tested against the coronavirus.

Kaletra, a combination HIV treatment sold by AbbVie Inc , has been considered a potential treatment for the virus, although Chinese investigators have reported that it failed to improve outcomes for seriously ill patients. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shinjini Ganguli)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below